Ces Urol 2008, 12(1):31-36 | DOI: 10.48095/cccu2008005

Prediction of the prostate cancer pathological classification

Otakar Čapoun, Marek Babjuk, Jan Dvořáček, Tomáš Hanuš, Libor Šafařík, Ivan Pavlík
Urologická klinika 1. LF UK a VFN, Praha

Aim:
We performed a retrospective analysis of pre-operative parameters in patients with prostate cancer (CaP) and assessed the risk of the locally advanced carcinoma after radical prostatectomy.

Material and methods:
Between years 2000 and 2006, 471 men with clinically organ confined CaP underwent radical prostatectomy (RP). All standard preoperative parameters were collected preoperatively Pathological stage and Gleason score (GS), as well as surgical margin status and perineural invasion in the surgical specimen were registered. An impact of the preoperative parameters on the pT stage was assessed by Spearman rank correlation coefficient method. Statistical significance was defined as p < 0.05.

Results:
The mean age was 62 years, the mean initial prostate specific antigen (PSA) level was 10.55 ng/ml, with cTlc stage presented 67.2 % men. The organ confined disease after RP was found in 72.9 % patiens, surgical GS higher than six was identified in 20,3 % cases. Positive surgical margin and perineural invasion was described in 12,7 % and 46,3 % specimen, respectively. All investigated preoperative parameters were found to have an impact on the pathological stage of prostate cancer.

Conclusion:
All standard preoperative parameters were statistically significant, with the highest risk of pT3 cancer for patients with the bioptical GS higher than seven, positive digital rectal examination and/or preoperative PSA level higher than 10 ng/ml.

Keywords: prostate cancer, radical prostatectomy

Received: May 17, 2008; Accepted: June 25, 2008; Published: January 1, 2008 


References

  1. Novotvary 2004 ČR, UZIS 2007.
  2. Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110-114. Go to original source... Go to PubMed...
  3. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169: 517-523. Go to original source... Go to PubMed...
  4. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90: 766-771. Go to original source... Go to PubMed...
  5. Makarov DV, Trock BJ, Humphreys EB, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007; 69: 1095-1101. Go to original source... Go to PubMed...
  6. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843-848. Go to original source... Go to PubMed...
  7. Song C, Kang T, Ro JY, Lee MS, Kim CS, Ahn H. Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 2005; 20: 262-266. Go to original source... Go to PubMed...
  8. Eskicorapci SY, Karabulut E, Türkeri L, et al. Validation of 2001 Partin tables in Turkey: a multicenter study. Eur Urol 2005; 47: 185-189. Go to original source... Go to PubMed...
  9. Graefen M, Augustin H, Karakiewicz PI, et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables Eur Urol 2003; 43: 6-10. Go to original source... Go to PubMed...
  10. Záleský M, Zachoval R, Šmerhovský Z, Lukeš M, Heráček J, Vik V, Klemenc V, Urban M. Možnosti stanovení lokálního rozsahu karcinomu prostaty před plánovanou radikální léčbou: prospektivní studie. Čas Lék čes 2007; 146: 793-800.
  11. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50: 125-128.
  12. Spigelman SS, McNeal JE, Freiha FS, Stamey TA. Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol 1986; 136: 1228-1230. Go to original source... Go to PubMed...
  13. Rørvik J, Halvorsen OJ, Servoll E, Haukaas S. Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br J Urol 1994; 73: 65-69. Go to original source... Go to PubMed...
  14. Oesterling JE, Chan DW, Epstein JI, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988; 139: 766-772. Go to original source... Go to PubMed...
  15. Partin AW, Carter HB, Chan DW, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990; 143: 747-752. Go to original source... Go to PubMed...
  16. Král M, Študent V, Vidlář A, Hrabec M, Marek D. Nomogram predikce up-gradingu Gleasonova skóre v biopsii prostaty. Čes Urol 2007; 11: 159-163.
  17. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 2002; 167: 117-122. Go to original source... Go to PubMed...
  18. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2000; 163: 174-178. Go to original source... Go to PubMed...
  19. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994; 44: 371-376. Go to original source... Go to PubMed...
  20. Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003; 170: 1792-1797. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit